Alprolix
Factor Factor IX is considered medically necessary if ANY ONE of the following is met:
• For long term bleeding prophylaxis in members with severe Hemophilia B (congenital factor IX deficiency or Christmas disease). o Prophylaxis is only indicated for individuals with severe hemophilia B as defined by factor IX < 1%. o 25-40 International Units/kg IV two times weekly is a commonly used regimen. o For Alprolix: The recommended starting regimens are either 50 IU/kg once weekly, or 100 IU/kg once every 10 days. o If criteria met, approve for Calendar Year.
• For the control of hemorrhage including surgical bleeding and hemarthrosis in members with Hemophilia B (congenital factor IX deficiency or Christmas disease). o If criteria met, approve according to the dosing chart below. • For the treatment of other factor deficiencies (e.g., Factors II, VII, VIII, and X).
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• For the treatment of hemophilia A members with inhibitors to Factor VIII.
• For the reversal of coumarin-induced anticoagulation.
• For the treatment of bleeding due to low levels of liver-dependent coagulation factors. NOTE: Kcentra is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy with acute major bleeding or the need for urgent surgery or other invasive procedure.
• Dosing should be individualized based on the patient's baseline INR value, body weight, and actual potency of Factor IX as stated on the product carton. 
